Alpha 1 Antitrypsin Deficiency Treatment Market to Reach a Valuation of US$2,908.1 mn by the End


Posted June 19, 2019 by snehatmr

Alpha 1 Antitrypsin Deficiency Treatment Market is Estimated to Reach a Valuation of US$2,908.1 mn by the End

 
The global alpha-1 antitrypsin deficiency treatment market is characterized by a large number of regional and global players, making its vendor landscape, a fragmented one, states Transparency Market Research (TMR) in its latest report. Leading companies within the market are: Teva Pharmaceutical Industries Ltd., Pfizer Inc., Baxter, Boehringer Ingelheim GmbH, Shire plc, Kamada Ltd., AstraZeneca, LFB Biomedicaments S.A., Grifols S.A., GlaxoSmithKline Plc., and CSL Behring LLC. It is anticipated that many new biotechnology companies will venture into the alpha-1 antitrypsin deficiency treatment market, and work towards the development of personalized medicines for genetically inherited disorders. They are also likely to invest extensively in R&D for coming up with novel treatment processes and for the development of stem cell based therapeutics.

Request A Sample: https://www.transparencymarketresearch.com/alpha-1-antitrypsin-deficiency-treatment-market.html

According to TMR, the global alpha-1 antitrypsin deficiency treatment market will expand at a more than healthy10.3% CAGR from 2017 to 2025, and be valued at US$2,908.1 mn by the end of 2025. On the basis of treatment type, the augmentation therapy segment has been leading, with the bronchodilator treatment segment trailing in the second position. On the basis of end user, the hospital segment emerged as the leading one, while the parenteral segment has emerged as the most popular route of administration. On the basis of geography, North America has been leading in the alpha-1 antitrypsin deficiency treatment market, on account of the rising diagnosis rate, increasing prevalence of alpha-1 antitrypsin deficiency, and high healthcare expenditure.

Market Players to Benefit from Investing in Emerging Nations

The recent advancements in the diagnosis of apha-1 antitrypsin deficiency, has boded well for the growth of the apha-1 antitrypsin deficiency treatment market and with the rising prevalence of respiratory diseases, it is slated that this market will continue to witness growth. As per a TMR analyst, “the high unmet medical needs in the developing nations as well as improvement in the healthcare facilities in these nations offers market players, lucrative opportunities to grow. Moreover, the support from government will also work in their favour. As per the Forum of International Respiratory Societies (FIRS), COPD is likely to be the fourth leading cause of death by 2030 and every year over 235 mn people across the globe are detected with asthma.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13214

Alpha-1 antitrypsin Supply Falling Short

Technological advancements have resulted in safer production and purification processes of alpha-1 antitrypsin making them free from virus and other contaminants such as protein. This in turn has increased the preference for plasma derived alpha-1 antitrypsin and IVIG. On the downside however, the global alpha-1 antitrypsin deficiency treatment market is challenged by the high cost of drugs and shortage of alpha-1 antitrypsin supply. The market is also restricted by limited plasma fractionation capacity and stringent regulations.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Phone 8208563687
Business Address pune
pune
Country India
Categories Blogging
Last Updated June 19, 2019